Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
September 16, 2019
Immunophenotyping of Acute Lymphoblastic Leukemia
Joseph A DiGiuseppe, Jolene L Cardinali
Cytometry. Part B, Clinical Cytometry
|
January 3, 2020
CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases
Katrina Collins, Jolene L Cardinali, Laila O Mnayer, et al.
Cytometry. Part B, Clinical Cytometry
|
September 3, 2017
PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data
Joseph A DiGiuseppe, Jolene L Cardinali, William N Rezuke, et al.
Archives of Pathology & Laboratory Medicine
|
September 4, 2020
Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey
Meghan M Hupp, Christine Bashleben, Jolene L Cardinali, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
September 16, 2019
Immunophenotyping of Acute Lymphoblastic Leukemia
Joseph A DiGiuseppe, Jolene L Cardinali
Cytometry. Part B, Clinical Cytometry
|
January 3, 2020
CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases
Katrina Collins, Jolene L Cardinali, Laila O Mnayer, et al.
Cytometry. Part B, Clinical Cytometry
|
September 3, 2017
PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data
Joseph A DiGiuseppe, Jolene L Cardinali, William N Rezuke, et al.
Archives of Pathology & Laboratory Medicine
|
September 4, 2020
Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey
Meghan M Hupp, Christine Bashleben, Jolene L Cardinali, et al.
Page
of 1